IMR

IMRICOR CDI FORUS [IMR]
Imricor Medical Systems, Inc., a medical device company, designs, manufactures, sells, and distributes magnetic resonance imaging (MRI) compatible products for cardiac catheter ablation procedures in the United States, Europe, and the Middle East. The company's products include Vision-MR Ablation Catheter 2.0, a MR-compatible cardiac ablation catheter; Vision-MR Diagnostic Catheter, a MR-compatible diagnostic catheter; NorthStar mapping system, a real-time, high-resolution soft tissue imaging of MRI to guide and visualize procedures with exceptional clarity; and Advantage-MR EP Recorder / Stimulator. The company through its Imricor Cardiovascular vertical provides integrated single session workflows for hospitals for MR imaging. It also offers Vision-MR Dispersive Electrode to minimize eddy currents induced on the device's conductive pads during MR scanning. Imricor Medical Systems, Inc. was incorporated in 2006 and is headquartered in Burnsville, Minnesota.
Healthcare · ASX Small Cap
$1.8850 -0.5%

Updated 9 Sep 2026 · Signals refresh every scan

Appeared in 2 consecutive scansFirst seen: 2026-02-25
Get alerts when IMR triggers a new signal
Free watchlist with daily scans for 2,200+ ASX stocks
Track IMR — Free

Active Signals

Bullish Signals

  • MACD momentum is losing steam
  • Volume surging at 2.8x normal while price falls — heavy selling pressure
  • Sitting near support — this level has held before and could attract buyers again
  • Trading above the 200-day average — the long-term trend is on your side
  • Strong cash runway (11 quarters)
  • Very high P/S ratio (5747.9x)
  • EPS estimates revised upward (+10pts)
  • CANSLIM I: Institutional ownership (16%)
  • Sentiment is mixed — no strong consensus either way
  • Positive long-term momentum — up 41% over the past year
  • The bigger volume days are the up days — volume-weighted momentum is positive (0.63%/day)
  • RBA hiking (-3pts)

Risk Signals

  • Revenue declining (-7%)
  • Piotroski F-Score weak (3/9, low-confidence approx)
  • Not enough chatter to gauge sentiment — defaulting to neutral

Expected next for IMR

18 Oct 2026Regulatory ApprovalEstimated from past filings
Window: 11 Oct to 25 Oct
The last 3 moved IMR 0.0% on the day, on average — an observation, not a guide to what happens next.
12 Nov 2026Quarterly Cash Flow Report (4C)Estimated from past filings
Window: 5 Nov to 19 Nov
The last 6 moved IMR 0.0% on the day, on average — an observation, not a guide to what happens next.
Each date is labelled with how it is known. A date estimated from past filings is inferred from this company's own filing rhythm — it is not a confirmed date and not a statement about what the company intends to do. See the whole ASX calendar →

Recent Catalysts

NONE S&P DJI Announces September 2026 Quarterly Rebalance
NONE FDA Accepts Imricor PMA Manufacturing Module
NONE Release from Voluntary Escrow
Announcement tone +3pts

Recent ASX Announcements

2026-09-04 S&P DJI Announces September 2026 Quarterly Rebalance PRICE SENSITIVE
2026-09-02 FDA Accepts Imricor PMA Manufacturing Module PRICE SENSITIVE
2026-08-28 Release from Voluntary Escrow
2026-08-27 Imricor and Philips Launch Commercial iMR Lab Solution PRICE SENSITIVE
2026-08-09 Imricor U.S. Commercial Momentum Accelerates PRICE SENSITIVE

Key Metrics

$690.2M
Market Cap
478K
Avg Volume
2.8x
Vol Ratio
$1.27 — $2.25
52-Week Range
0.1%
Short Interest
N/A
Cash Runway
-143.1%
ROE
N/A
Profit Margin

CANSLIM Analysis

FactorRatingDetail
CCurrent EPSfailEPS Growth: 0%
AAnnual EarningsfailCAGR: 0%
NNew Highs / Catalystsneutral
SSupply & DemandneutralFloat: 86%
LLeader vs LaggardlaggardRS: 0
IInstitutional SponsorshippassInst: 16%
MMarket DirectionneutralNeutral

Sector: Healthcare

110 tickers in this sector

View all Healthcare signals →Browse all ASX tickers A–Z →
Related Tickers
NUZ +37.1%IPD +20.0%HIQ +16.7%AVE +15.0%CVB +11.1%
Compare:IMR vs NUZIMR vs IPDIMR vs HIQ
Share this analysis

Track IMR and 2,200+ ASX stocks

Get free access to Scout's AI-powered dashboard with daily scans, watchlist alerts, and exit management for every ASX small cap.

Open Dashboard — Free Free Screener
No credit card required